Current role of echocardiography in cardiac resynchronization therapy

被引:0
作者
Donato Mele
Matteo Bertini
Michele Malagù
Marianna Nardozza
Roberto Ferrari
机构
[1] University of Ferrara,Centro Cardiologico Universitario and LTTA Centre
[2] Azienda Ospedaliero-Universitaria,Noninvasive Cardiology Unit
[3] Maria Cecilia Hospital,undefined
[4] GVM Care & Research,undefined
[5] E.S. Health Science Foundation,undefined
来源
Heart Failure Reviews | 2017年 / 22卷
关键词
Heart failure; Cardiac resynchronization therapy; Echocardiography; Speckle tracking echocardiography; Pacemaker;
D O I
暂无
中图分类号
学科分类号
摘要
Cardiac resynchronization therapy (CRT) is an established treatment for patients with heart failure and left ventricular systolic dysfunction. Patients are usually assessed by echocardiography, which provides a number of anatomical and functional information used for cardiac dyssynchrony assessment, prognostic stratification, identification of the optimal site of pacing in the left ventricle, optimization of the CRT device, and patient follow-up. Compared to other cardiac imaging techniques, echocardiography has the advantage to be non-invasive, repeatable, and safe, without exposure to ionizing radiation or nefrotoxic contrast. In this article, we review current evidence about the role of echocardiography before, during, and after the implantation of a CRT device.
引用
收藏
页码:699 / 722
页数:23
相关论文
共 657 条
[1]  
Ponikowski P(2016)ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology Eur J Heart Fail 18 891-975
[2]  
Voors AA(2015)Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging Eur Heart J Cardiovasc Imaging 16 233-270
[3]  
Anker SD(2007)Guidelines for cardiac pacing and cardiac resynchronization therapy: the Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association Eur Heart J 28 2256-2295
[4]  
Lang RM(2005)SCARS Investigators. Predictors of lack of response to resynchronization therapy Am J Cardiol 95 1436-1440
[5]  
Badano LP(2009)Identification of “super-responders” to cardiac resynchronization therapy: the importance of symptom duration and left ventricular geometry Europace 11 343-349
[6]  
Mor-Avi V(2010)Characterization of super-response to cardiac resynchronization therapy Heart Rhythm 7 885-889
[7]  
Vardas PE(2010)Decreased likelihood of response to cardiac resynchronization in patients with severe heart failure Eur J Heart Fail 12 283-287
[8]  
Auricchio A(2010)Identification and characterization of super-responders after cardiac resynchronization therapy Am J Cardiol 105 1327-1335
[9]  
Blanc JJ(2011)Predicting hyperresponse among pacemaker-dependent nonischemic cardiomyopathy patients upgraded to cardiac resynchronization J Cardiovasc Electrophysiol 22 905-911
[10]  
Díaz-Infante E(2011)Hyperresponders to cardiac resynchronization therapy: timing is everything ... but size still matters! J Cardiovasc Electrophysiol 22 912-914